Standard Precautions Versus Contact Additional Precautions Against Multi-drug Resistant Bacteria in Intensive Care Unit (PSBMR) (PSBMR)
|ClinicalTrials.gov Identifier: NCT02890433|
Recruitment Status : Completed
First Posted : September 7, 2016
Last Update Posted : September 7, 2016
|Condition or disease|
|Multi-drug Resistant Bacteria|
The national recommendations promote the applying of the Contact Additional Precautions (CAP) with the Standard Precautions (SP) to limit the transmission of multi-drug resistant (MDR) bacteria. However, that could entail more costs and a reduction of quality of the patient care.
This study seeks showing it in way of a non-interventional research in a resuscitation unit. Two periods are compared for noticing the rates of MDR bacteria contaminations.
|Study Type :||Observational|
|Actual Enrollment :||3124 participants|
|Official Title:||Are Standard Precautions as Efficient as Contact Additional Precautions Against the Transmission of Multi-drug Resistant Bacteria in Intensive Care Unit ?|
|Study Start Date :||June 2015|
|Actual Primary Completion Date :||December 2015|
|Actual Study Completion Date :||December 2015|
- Rate of Meticillin Resistant Staphylococcus Aureus (MRSA) and Enterobacteriaceae producing Extended Spectrum Beta-Lactamase (EESBL) per 1000 hospitalization days [ Time Frame: 1000 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02890433
|Metz Cedex 03, France, 57085|
|Principal Investigator:||Jocelyne SELLIES, MD||CHR Metz-Thionville|